Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veli-Matti Kosma

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|June 18, 2013
[Pathology at the interface of basic and clinical research]Olli Carpén, Veli-Matti Kosma
International Journal of Cancer|March 3, 2007
Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini reviewJohanna M Pellikainen, Veli-Matti Kosma
Anticancer Research|May 17, 2002
Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX)Pasi Hakulinen, Veli-Matti Kosma, Hannu Komulainen
International Journal of Clinical and Experimental Pathology|January 2, 2016
KDM4A, KDM4B and KDM4C in non-small cell lung cancerYlermi Soini, Veli-Matti Kosma, Risto Pirinen
BMC Medical Imaging|October 19, 2023
Nuclei instance segmentation from histopathology images using Bayesian dropout based deep learningNaga Raju Gudhe, Veli-Matti Kosma, Hamid Behravan, et al.
Anticancer Research|February 26, 2004
alpha-, beta- and chi-catenin expression in human pancreatic cancerKristiina Julkunen, Kimmo Mäkinen, Vesa Kärjä, et al.
American Journal of Perinatology|January 24, 2003
Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysisSari Toivonen, Seppo Heinonen, Maarit Anttila, et al.
Anticancer Research|June 13, 2014
XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancerMaria Tengström, Arto Mannermaa, Veli-Matti Kosma, et al.
BMC Cancer|June 20, 2012
SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Maria Tengström, Arto Mannermaa, Veli-Matti Kosma, et al.
Fetal Diagnosis and Therapy|June 12, 2004
Obstetric prognosis after placental abruptionSari Toivonen, Seppo Heinonen, Maarit Anttila, et al.
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Duodecim; Laaketieteellinen Aikakauskirja|June 18, 2013
[Pathology at the interface of basic and clinical research]Olli Carpén, Veli-Matti Kosma
International Journal of Cancer|March 3, 2007
Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini reviewJohanna M Pellikainen, Veli-Matti Kosma
Anticancer Research|May 17, 2002
Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX)Pasi Hakulinen, Veli-Matti Kosma, Hannu Komulainen
International Journal of Clinical and Experimental Pathology|January 2, 2016
KDM4A, KDM4B and KDM4C in non-small cell lung cancerYlermi Soini, Veli-Matti Kosma, Risto Pirinen
BMC Medical Imaging|October 19, 2023
Nuclei instance segmentation from histopathology images using Bayesian dropout based deep learningNaga Raju Gudhe, Veli-Matti Kosma, Hamid Behravan, et al.
Anticancer Research|February 26, 2004
alpha-, beta- and chi-catenin expression in human pancreatic cancerKristiina Julkunen, Kimmo Mäkinen, Vesa Kärjä, et al.
American Journal of Perinatology|January 24, 2003
Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysisSari Toivonen, Seppo Heinonen, Maarit Anttila, et al.
Anticancer Research|June 13, 2014
XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancerMaria Tengström, Arto Mannermaa, Veli-Matti Kosma, et al.
BMC Cancer|June 20, 2012
SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Maria Tengström, Arto Mannermaa, Veli-Matti Kosma, et al.
Fetal Diagnosis and Therapy|June 12, 2004
Obstetric prognosis after placental abruptionSari Toivonen, Seppo Heinonen, Maarit Anttila, et al.
Pageof 25